|
Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma Lung …
Lung Disease News GSK Expands Its COPD And Asthma Portfolio Across The US. Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled … |
View full post on asthma – Google News